Literature DB >> 16622883

Scalable production of adeno-associated virus type 2 vectors via suspension transfection.

Joon Young Park1, Byung-Pil Lim, Kyuhyun Lee, Young-Gun Kim, Eui-Cheol Jo.   

Abstract

Vectors derived from adeno-associated virus type 2 (AAV2) are promising gene delivery vehicles, but it is still challenging to get the large number of recombinant adeno-associated virus (rAAV) particles required for large animal and clinical studies. Current transfection technology requires adherent cultures of HEK 293 cells that can only be expanded by preparing multiple culture plates. A single large-scale suspension culture could replace these multiple culture preparations, but there is currently no effective co-transfection scheme for generating rAAV from cells in suspension culture. Here, we weaned HEK 293 cells to suspension culture using hydrogel-coated six-well culture plates and established an efficient transfection strategy suitable for these cells. Then the cultures were gradually scaled up. We used linear polyethylenimine (PEI) to mediate transfection and obtained high transfection efficiencies ranging from 54% to 99%, thereby allowing efficient generation of rAAV vectors. Up to 10(13) rAAV particles and, more importantly, up to 10(11) infectious particles were generated from a 2-L bioreactor culture. The suspension-transfection strategy of this study facilitates the homogeneous preparation of rAAV at a large scale, and holds further potential as the basis for establishing a manufacturing process in a larger bioreactor. 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622883     DOI: 10.1002/bit.20776

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

Review 1.  Progress and challenges in viral vector manufacturing.

Authors:  Johannes C M van der Loo; J Fraser Wright
Journal:  Hum Mol Genet       Date:  2015-10-30       Impact factor: 6.150

Review 2.  Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies.

Authors:  Nathalie Clément; David R Knop; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2009-08       Impact factor: 5.695

Review 3.  Large-scale recombinant adeno-associated virus production.

Authors:  Robert M Kotin
Journal:  Hum Mol Genet       Date:  2011-04-29       Impact factor: 6.150

4.  The transient expression of CHIKV VLP in large stirred tank bioreactors.

Authors:  Peifeng Chen; Jacob Demirji; Vera B Ivleva; Joe Horwitz; Richard Schwartz; Frank Arnold
Journal:  Cytotechnology       Date:  2019-09-27       Impact factor: 2.058

5.  Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.

Authors:  Joshua C Grieger; Stephen M Soltys; Richard Jude Samulski
Journal:  Mol Ther       Date:  2015-10-06       Impact factor: 11.454

Review 6.  Transient transfection methods for clinical adeno-associated viral vector production.

Authors:  J Fraser Wright
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

7.  Polyethyleneimine-based transient gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells.

Authors:  David L Hacker; Divor Kiseljak; Yashas Rajendra; Sarah Thurnheer; Lucia Baldi; Florian M Wurm
Journal:  Protein Expr Purif       Date:  2013-09-08       Impact factor: 1.650

8.  Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences.

Authors:  Prasad D Trivedi; Chenghui Yu; Payel Chaudhuri; Evan J Johnson; Tina Caton; Laura Adamson; Barry J Byrne; Nicole K Paulk; Nathalie Clément
Journal:  Mol Ther Methods Clin Dev       Date:  2021-12-25       Impact factor: 5.849

9.  Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery.

Authors:  Parminder Singh Chahal; Erica Schulze; Rosa Tran; Johnny Montes; Amine A Kamen
Journal:  J Virol Methods       Date:  2013-11-13       Impact factor: 2.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.